Temporomandibular Disorders Management—What’s New? A Scoping Review
Dentistry Journal,
Journal Year:
2024,
Volume and Issue:
12(6), P. 157 - 157
Published: May 23, 2024
Temporomandibular
disorders
include
various
conditions
that
impact
the
masticatory
system,
affecting
its
structure,
function,
or
physiology.
Clinicians
face
a
complex
array
of
therapeutic
options
when
treating
this
group
diseases,
emphasizing
importance
evaluating
current
evidence
to
guide
decisions
in
patient
care.
The
main
objective
article
is
conduct
scoping
review
on
available
treatment
approaches
manage
temporomandibular
(TMDs).
An
extensive
search
literature
was
performed
Scopus,
Pubmed,
Embase,
and
Web
Science.
Systematic
reviews
published
last
5
years
were
considered.
Out
2183
publications
identified,
109
studies
included
review.
Among
them,
39
articles
focused
non-invasive
approach,
while
120
delved
into
minimally
invasive
15
explored
surgical
approach.
Non-invasive
conservative
like
cognitive-behavioral
therapy,
physical
acupuncture
offer
effective
pain
management
functional
improvements
TMDs.
Emerging
treatments
promising
alternatives
for
these
disorders.
Surgery
should
be
reserved
severe
cases,
with
therapies
used
conjunction
procedures
optimal
outcomes.
Language: Английский
Leukocytes within Autologous Blood Concentrates Have No Impact on the Growth and Proliferation of Human Primary Osteoblasts: An In Vitro Study
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(8), P. 4542 - 4542
Published: April 21, 2024
Platelet-rich
fibrin
(PRF)
is
a
widely
used
autologous
blood
concentrate
in
regenerative
medicine.
This
study
aimed
to
characterize
the
cellular
composition
and
distribution
of
different
PRF
matrices
generated
by
high
(710
g)
low
(44
relative
centrifugal
forces
(RCFs)
analyze
their
bioactivity
on
human
primary
osteoblasts
(pOBs).
was
separated
into
upper
layer
(UL)
buffy
coat
(BC)
fractions,
contents
were
assessed
using
histological
immunohistochemical
staining.
The
release
platelet-derived
growth
factor
(PDGF)
transforming
(TGF-β)
quantified
an
ELISA.
Indirect
treatment
pOBs
performed
evaluate
cell
viability
morphology.
A
analysis
revealed
higher
quantities
leukocytes
platelets
low-RCF
PRF.
TGF-β
significantly
compared
high-RCF
All
fractions
promoted
pOB
proliferation
regardless
centrifugation
protocol
used.
showed
levels
than
These
findings
contribute
understanding
mechanisms
provide
insights
optimizing
protocols
for
bone
regeneration,
advancing
medicine,
improving
patient
outcomes.
Language: Английский